Emerging Infectious Diseases (EIDs) are novel or re-emerging infections that pose a significant threat to global public health. These diseases often result from the evolution of existing pathogens, zoonotic spillover, or changes in human behavior and ecosystems. Recent examples include the COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2. EIDs can rapidly spread worldwide due to increased global travel and interconnectedness. Factors contributing to the emergence of infectious diseases include climate change, urbanization, deforestation, and the expansion of agricultural activities. Surveillance and early detection are crucial for preventing and controlling EIDs, as timely intervention can mitigate their impact. Multidisciplinary approaches involving public health, veterinary medicine, and environmental science are essential for understanding and managing the complex dynamics of EIDs. Global collaboration and information-sharing play a pivotal role in addressing emerging infectious threats. Vaccines, antiviral drugs, and public health measures are vital tools in managing EIDs, emphasizing the importance of research and innovation. Continuous monitoring and adaptive strategies are necessary to stay ahead of the evolving nature of infectious diseases, ensuring a proactive and effective response to future health challenges.
Speaker lineup for this track will be announced soon.
Browse all speakers →Background : Viruses are potential biological weapons with the ability to destroy health and economic systems; COVID-19 is a living example of this, and we are all too familiar with the disasters…
Background: Corona virus disease 2019 (COVID-19) has become the most widespread global acute infectious disease in the past century, resulting in serious damages to human health, economic development…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Emerging Infectious Diseases work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Emerging Infectious Diseases research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Emerging Infectious Diseases track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Emerging Infectious Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Emerging Infectious Diseases are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Emerging Infectious Diseases track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
